Notes in Mycosis fungoides / Sezary syndrome

To Subscribe, use this Key

Status	Last Update	Fields
Published	02/18/2024	Haem \| Mycosis fungoides \| 1.1 \| General description
Published	02/18/2024	Haem \| Mycosis fungoides \| 1.2 \| Diagnostic criteria
Published	02/18/2024	Haem \| Mycosis fungoides \| 1.3 \| Epidemiology
Published	02/18/2024	Haem \| Mycosis fungoides \| 1.4 \| Aetiology / Risk Factors
Published	02/18/2024	Haem \| Mycosis fungoides \| 1.5 \| Pathogenesis
Published	02/18/2024	Haem \| Mycosis fungoides \| 1.6  \| Biologic behaviour
Published	02/18/2024	Haem \| Mycosis fungoides \| 1.7 \| DDx
Published	02/18/2024	Haem \| Mycosis fungoides \| 1.8 \| Clinical features
Published	02/18/2024	Haem \| Mycosis fungoides \| 2.1 \| Workup
Published	02/18/2024	Haem \| Mycosis fungoides \| 1.9 \| Microscopic appearance
Published	02/18/2024	Haem \| Mycosis fungoides \| 2.2 \| Staging (TNMB)
Published	02/18/2024	Haem \| Mycosis fungoides \| 3.1 \|  Management overview
Published	02/18/2024	Haem \| Mycosis fungoides \| 2.3 \| Prognosis by stage
Published	02/18/2024	Haem \| Mycosis fungoides \| 4.1 \| RT technique \| Localised fields
Published	02/18/2024	Haem \| Mycosis fungoides \| 4.2 \| RT technique \| Total skin electrons
Published	02/18/2024	Haem \| Mycosis fungoides \| 3.2.1 \| Management \| Early disease \| Stage IA (patches/plaques <10% TBSA) and stage IB-IIA (patches/plaques >10% TBSA…
Published	02/18/2024	Haem \| Mycosis fungoides \| 3.4.1 \| Management \| Skin-directed therapies \| List \| List available skin-directed therapies for mycosis fungoides
Published	02/18/2024	Haem \| Mycosis fungoides \| 3.4.2 \| Management \| Skin-directed therapies \| Topical corticosteroids
Published	02/18/2024	Haem \| Mycosis fungoides \| 3.4.8 \| Management \| Skin-directed therapies \| Total skin electron beam therapy (TSEBT)
Published	02/18/2024	Haem \| Mycosis fungoides \| 3.4.3 \| Management \| Skin-directed therapies \| Topical chemotherapy
Published	02/18/2024	Haem \| Mycosis fungoides \| 3.4.4 \| Management \| Skin-directed therapies \| Topical retinoids
Published	02/18/2024	Haem \| Mycosis fungoides \| 3.4.5 \| Management \| Skin-directed therapies \| Imiquimod
Published	02/18/2024	Haem \| Mycosis fungoides \| 3.4.6 \| Management \| Skin-directed therapies \| Phototherapy
Published	02/18/2024	Haem \| Mycosis fungoides \| 3.4.7 \| Management \| Skin-directed therapies \| Localised RT
Published	02/18/2024	Haem \| Mycosis fungoides \| 3.3.5 \| Management \| Advanced \| Aggressive disease
Published	02/18/2024	Haem \| Mycosis fungoides \| 3.6 \| Management \| Symptom control
Published	02/18/2024	Haem \| Mycosis fungoides \| 3.7 \| Management \| Allogeneic stem cell transplant
Published	02/18/2024	Haem \| Mycosis fungoides \| 3.5 \| Management \| Systemic chemotherapy
Published	02/18/2024	Haem \| Mycosis fungoides \| 3.3.2 \| Management \| Advanced \| T3 (cutaneous tumours)
Published	02/18/2024	Haem \| Mycosis fungoides \| 3.3.3 \| Management \| Advanced \| T4 (Generalised erythroderma)
Published	02/18/2024	Haem \| Mycosis fungoides \| 3.3.4 \| Management \| Advanced \| Extracutaneous disease B1, N3, M1
Published	02/18/2024	Haem \| Mycosis fungoides \| 3.3.1 \| Management \| Advanced disease
Status	Last Update	Fields